Drug intelligence / Profile preview

Carbon monoxide

Development stage
Phase 2
Lead developer
Hillhurst Biopharmaceuticals
Modality
Small Molecules
Administration
Inhalation
01

Overview

Carbon monoxide is a colorless, odorless, and tasteless gas used primarily as a marker of respiratory status in spirometry tests. It exerts its biological effects by binding strongly to heme-containing proteins such as hemoglobin and myoglobin. The affinity of carbon monoxide for hemoglobin is over 200 times greater than that of oxygen, leading to the formation of carboxyhemoglobin (COHb), which reduces the oxygen-carrying capacity of blood and impairs tissue oxygen delivery. Carbon monoxide also binds to other heme proteins involved in critical physiological processes including nitric oxide signaling (nitric oxide synthase, guanylyl cyclase), prostaglandin synthesis (cyclooxygenase), mitochondrial respiration (cytochrome c oxidase), steroid metabolism (cytochrome P450), redox balance (catalase, peroxidases), and regulation of circadian rhythm via transcription factors like NPAS2. While high levels are toxic and can cause hypoxic injury—especially in organs with high oxygen demand such as the brain and heart—recent research has explored therapeutic uses for controlled low-dose administration due to its anti-inflammatory and organ-protective properties[1][4][6].

Other names
COcarbonic oxideflue gasexhaust gas
02

Targets

COXCyp (Cyclophilin family)COX7C (Cytochrome c oxidase subunit 7C, mitochondrial)NOS1 (nNOS)sGC (Soluble Guanylyl Cyclase)NeuraminidaseLPO (Lactoperoxidase)

Beyond the preview

Go deeper on Carbon monoxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbon monoxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call